Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies

International Review of Psychiatry

Volumn 21, Issue 4, 2009, Pages 323-335

  Gonul, Ali Saffet ^a,b   Coburn, Kerry ^b   Kula, Mustafa ^c  

^a School of Medicine   (Turkey)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; 1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; 3 [3 [3 (18F)FLUOROPROPYL]THIO] 1,2,5 THIADIAZOL 4 YL 1,2,5,6 TETRAHYDRO 1 METHYLPYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE C 11; ANTIDEPRESSANT AGENT; DASB C 11; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODOBENZAMIDE I 123; LEVOTHYROXINE; LITHIUM; MOOD STABILIZER; MUSCARINIC M2 RECEPTOR; NEUROTRANSMITTER; RACLOPRIDE C 11; RADIOLIGAND; SEROTONIN; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ADJUVANT THERAPY; ANXIETY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN METABOLISM; CAUDATE NUCLEUS; CINGULATE GYRUS; CORPUS STRIATUM; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOPAMINE METABOLISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; FRONTAL CORTEX; FRONTAL LOBE; GLUCOSE UTILIZATION; HUMAN; INSULA; INTERMETHOD COMPARISON; LIMBIC SYSTEM; MAJOR DEPRESSION; MANIA; METABOLIC RATE; MONOTHERAPY; NEUROMODULATION; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; PSYCHOSIS; RECEPTOR BINDING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; THALAMUS; TISSUE DISTRIBUTION; TISSUE STRUCTURE;

BIPOLAR DISORDER; BLOOD GLUCOSE; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DOMINANCE, CEREBRAL; ENERGY METABOLISM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NERVE NET; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REGIONAL BLOOD FLOW; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70350681126     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260902962131     Document Type: Review

References (74)

1. Acton, P. D. (2004). Image analysis in brain SPECT and PET. In P. J. Ell & S. S. Gambhir (Eds.), Nuclear medicine in clinical diagnosis and treatment (pp. 1341-1353). New York: Churchill Livingstone Press.
2. Adler, C. M., DelBello, M. P., Jarvis, K., Levine, A., Adams, J., & Strakowski, S. M. (2007). Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biological Psychiatry, 61, 776-781.
3. al-Mousawi, A. H., Evans, N., Ebmeier, K. P., Roeda, D., Chaloner, F., & Ashcroft, G. W. (1996). Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. British Journal of Psychiatry, 169, 509-516.
4. Altshuler, L., Bookheimer, S., Proenza, M. A., Townsend, J., Sabb, F., Firestine, A. et al. (2005). Increased amygdala activation during mania: A functional magnetic resonance imaging study. American Journal of Psychiatry, 162, 1211-1213. (Pubitemid 40770709)
5. Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S. et al. (2000). Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry, 157, 1108-1114.
6. Angst, J., Gamma, A., Benazzi, F., Ajdacic, V., Eich, D., & Rossler, W. (2003). Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. Journal of Affective Disorders, 73, 133-146.
7. Bauer, M., London, E. D., Rasgon, N., Berman, S. M., Frye, M. A., Altshuler, L. L. et al. (2005). Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Molecular Psychiatry, 10, 456-469.
8. Baxter Jr, L. R., Phelps, M. E., Mazziotta, J. C., Schwartz, J. M., Gerner, R. H., Selin, C. E. et al. (1985). Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Archives of General Psychiatry, 42, 441-447.
9. Baxter Jr, L. R., Schwartz, J. M., Phelps, M. E., Mazziotta, J. C., Guze, B. H., Selin, C. E. et al. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry, 46, 243-250.
10. Bearden, C. E., Thompson, P. M., Dalwani, M., Hayashi, K. M., Lee, A. D., Nicoletti, M. et al. (2007). Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biological Psychiatry, 62, 7-16.
11. Benabarre, A., Vieta, E., Martinez-Aran, A., Garcia-Garcia, M., Martin, F., Lomena, F. et al. (2005). Neuropsychological disturbances and cerebral blood flow in bipolar disorder. The Australian and New Zealand Journal of Psychiatry, 39, 227-234.
12. Blumberg, H. P., Stern, E., Martinez, D., Ricketts, S., de Asis, J., White, T. et al. (2000). Increased anterior cingulate and caudate activity in bipolar mania. Biological Psychiatry, 48, 1045-1052.
13. Blumberg, H. P., Stern, E., Ricketts, S., Martinez, D., de Asis, J., White, T. et al. (1999). Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. American Journal of Psychiatry, 156, 1986-1988.
14. Bonne, O., Krausz, Y., Gorfine, M., Karger, H., Gelfin, Y., Shapira, B. et al. (1996). Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. Journal of Affective Disorders, 41, 163-171.
15. Brooks III, J. O., Wang, P. W., Strong, C., Sachs, N., Hoblyn, J. C., Fenn, R. et al. (2006). Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. Bipolar disorders, 8, 248-254.
16. Buchsbaum, M. S., Wu, J., DeLisi, L. E., Holcomb, H., Kessler, R., Johnson, J. et al. (1986). Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorders, 10, 137-152.
17. Cannon, D. M., Carson, R. E., Nugent, A. C., Eckelman, W. C., Kiesewetter, D. O., Williams, J. et al. (2006a). Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Archives of General Psychiatry, 63, 741-747.
18. Cannon, D. M., Ichise, M., Fromm, S. J., Nugent, A. C., Rollis, D., Gandhi, S. K. et al. (2006b). Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry, 60, 207-217.
19. Carter, C. S., Braver, T. S., Barch, D. M., Botvinick, M. M., Noll, D., & Cohen, J. D. (1998). Anterior cingulate cortex, error detection, and the online monitoring of performance. Science, 280, 747-749. (Pubitemid 28243351)
20. Coburn, K. L., Lauterbach, E. C., Boutros, N. N., Black, K. J., Arciniegas, D. B., & Coffey, C. E. (2006). The value of quantitative electroencephalography in clinical psychiatry: A report by the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 460-500.
21. Cohen, R. M., Semple, W. E., Gross, M., Nordahl, T. E., King, A. C., Pickar, D. et al. (1989). Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology, 2, 241-254.
22. Culha, A. F., Osman, O., Dogangun, Y., Filiz, K., Suna, K., Kalkan, O. N. et al. (2008). Changes in regional cerebral blood flow demonstrated by (99m)Tc-HMPAO SPECT in euthymic bipolar patients. European Archives of Psychiatry and Clinical Neuroscience, 258, 144-151.
23. Das, P., Kemp, A. H., Liddell, B. J., Brown, K. J., Olivieri, G., Peduto, A. et al. (2005). Pathways for fear perception: Modulation of amygdala activity by thalamo-cortical systems. NeuroImage, 26, 141-148.
24. Drevets, W. C. (1999). Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Sciences, 877, 614-637.
25. Drevets, W. C. (2000). Neuroimaging studies of mood disorders. Biological Psychiatry, 48, 813-829.
26. Drevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E. (2002). Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacology, Biochemistry, and Behaviour, 71, 431-447.
27. Drevets, W. C., Price, J. L., Simpson Jr., J. R., Todd, R. D., Reich, T., Vannier, M. et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824-827.
28. Dunn, R. T., Kimbrell, T. A., Ketter, T. A., Frye, M. A., Willis, M. W., Luckenbaugh, D. A. et al. (2002). Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biological Psychiatry, 51, 387-399.
29. Dunn, R. T., Willis, M. W., Benson, B. E., Repella, J. D., Kimbrell, T. A., Ketter, T. A. et al. (2005). Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Research, 140, 181-198.
30. Fornito, A., Malhi, G. S., Lagopoulos, J., Ivanovski, B., Wood, S. J., Saling, M. M. et al. (2008). Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Research, 162, 123-132.
31. Fuster, J. M. (2002). Frontal lobe and cognitive development. Journal of Neurocytology, 31, 373-385.
32. Ginovart, N. (2005). Imaging the dopamine system with in vivo [11C]raclopride displacement studies: Understanding the true mechanism. Molecular Imaging & Biology, 7, 45-52.
33. Goodwin, G. M., Cavanagh, J. T., Glabus, M. F., Kehoe, R. F., O'Carroll, R. E., & Ebmeier, K. P. (1997). Uptake of 99mTcexametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: Associations with mania. British Journal of Psychiatry, 170, 426-430.
34. Gyulai, L., Alavi, A., Broich, K., Reilley, J., Ball, W. B., & Whybrow, P. C. (1997). I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study. Biological Psychiatry, 41, 152-161.
35. Herscovitch, P., Mintun, M. A., & Raichle, M. E. (1985). Brain oxygen utilization measured with oxygen-15 radiotracers and positron emission tomography: Generation of metabolic images. Journal of Nuclear Medicine, 26, 416-417.
36. Ichimiya, T., Suhara, T., Sudo, Y., Okubo, Y., Nakayama, K., Nankai, M. et al. (2002). Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biological Psychiatry, 51, 715-722.
37. Ito, H., Kawashima, R., Awata, S., Ono, S., Sato, K., Goto, R. et al. (1996). Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. Journal of Nuclear Medicine, 37, 410-414.
38. Javadapour, A., Malhi, G. S., Ivanovski, B., Chen, X., Wen, W., & Sachdev, P. (2007). Increased anterior cingulate cortex volume in bipolar I disorder. Australian and New Zealand Journal of Psychiatry, 41, 910-916.
39. Ketter, T. A., Kimbrell, T. A., George, M. S., Dunn, R. T., Speer, A. M., Benson, B. E. et al. (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry, 49, 97-109.
40. Krawczyk, D. C. (2002). Contributions of the prefrontal cortex to the neural basis of human decision making. Neuroscience and Biobehavioral Reviews, 26, 631-664.
41. Kruger, S., Alda, M., Young, L. T., Goldapple, K., Parikh, S., & Mayberg, H. S. (2006). Risk and resilience markers in bipolar disorder: Brain responses to emotional challenge in bipolar patients and their healthy siblings. American Journal of Psychiatry, 163, 257-264.
42. Kruger, S., Seminowicz, D., Goldapple, K., Kennedy, S. H., & Mayberg, H. S. (2003). State and trait influences on mood regulation in bipolar disorder: Blood flow differences with an acute mood challenge. Biological Psychiatry, 54, 1274-1283.
43. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea-Ponce, Y., Zoghbi, S. S. et al. (1995). SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine, 36, 1182-1190.
44. Mah, L., Zarate Jr, C. A., Singh, J., Duan, Y. F., Luckenbaugh, D. A., Manji, H. K. et al. (2007). Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry, 61, 765-775.
45. Mazière, B., & Halldin, C. (2004). PET tracers for brain imaging. In P. J. Ell & S. S. Gambhir (Eds.), Nuclear medicine in clinical diagnosis and treatment (pp. 1295-1329). China: Churchill Livingstone Press.
46. Mazière, M., Berger, G., & Comar, D. (1982). C-11 Radiopharmaceuticals for brain receptor studies. In R. M. Lambrecht & N. Morcos (Eds.), Applications of Nuclear and Radiochemistry (pp. 251-270). New York: Pergamon Press.
47. Miklowitz, D. J., & Johnson, S. L. (2006). The psychopathology and treatment of bipolar disorder. Annual Review of Clinical Psychology, 2, 199-235.
48. Mirza, M., Tutus, A., Erdogan, F., Kula, M., Tomar, A., Silov, G. et al. (1998). Interictal SPECT with Tc-99m HMPAO studies in migraine patients. Acta Neurologica Belgica, 98, 190-194.
49. Montz, A. R., Jimenez, V. A., Coullaut, J. J., Lopez-Ibor, A. J. J., & Carreras Delgado, J. L. (2002). [PET in neurology and psychiatry I. PET with FDG in the study of the CNS]. Revista Espanola de Medicina Nuclear, 21, 370-386, quiz 387-1379
50. Narrow, W. E., Rae, D. S., Robins, L. N., & Regier, D. A. (2002). Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile two surveys' estimates. Archives of General Psychiatry, 59, 115-123.
51. O'Connell, R. A., Van Heertum, R. L., Luck, D., Yudd, A. P., Cueva, J. E., Billick, S. B. et al. (1995). Single-photon emission computed tomography of the brain in acute mania and schizophrenia. Journal of Neuroimaging, 5, 101-104.
52. Ongur, D., & Price, J. L. (2000). The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex, 10, 206-219.
53. Oquendo, M. A., Hastings, R. S., Huang, Y. Y., Simpson, N., Ogden, R. T., Hu, X. Z. et al. (2007). Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Archives of General Psychiatry, 64, 201-208.
54. Pearlson, G. D., Wong, D. F., Tune, L. E., Ross, C. A., Chase, G. A., Links, J. M. et al. (1995). In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Archives of General Psychiatry, 52, 471-477.
55. Phillips, M. L., Ladouceur, C. D., & Drevets, W. C. (2008a). A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry, 13, 833-857.
56. Phillips, M. L., Travis, M. J., Fagiolini, A., & Kupfer, D. J. (2008b). Medication effects in neuroimaging studies of bipolar disorder. American Journal of Psychiatry, 165, 313-320.
57. Procyk, E., & Goldman-Rakic, P. S. (2006). Modulation of dorsolateral prefrontal delay activity during self-organized behavior. Journal of Neuroscience, 26, 11313-11323.
58. Roth, R. M., Koven, N. S., Randolph, J. J., Flashman, L. A., Pixley, H. S., Ricketts, S. M. et al. (2006). Functional magnetic resonance imaging of executive control in bipolar disorder. Neuroreport, 17, 1085-1089.
59. Rubin, E., Sackeim, H. A., Prohovnik, I., Moeller, J. R., Schnur, D. B., & Mukherjee, S. (1995). Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiatry Research, 61, 1-10.
60. Rubinsztein, J. S., Fletcher, P. C., Rogers, R. D., Ho, L. W., Aigbirhio, F. I., Paykel, E. S. et al. (2001). Decision-making in mania: A PET study. Brain, 124, 2550-2563.
61. Rush, A. J., Schlesser, M. A., Stokely, E., Bonte, F. R., & Altshuller, K. Z. (1982). Cerebral blood Fow in depression and mania. Psychopharmacology Bulletin, 1, 6-7.
62. Schwartz, J. M., Baxter Jr, L. R., Mazziotta, J. C., Gerner, R. H., & Phelps, M. E. (1987). The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy. JAMA, 258, 1368-1374.
63. Silfverskiold, P., & Risberg, J. (1989). Regional cerebral blood flow in depression and mania. Archives of General Psychiatry, 46, 253-259.
64. Strakowski, S. M., DelBello, M. P., Adler, C., Cecil, D. M., & Sax, K. W. (2000). Neuroimaging in bipolar disorder. Bipolar Disorders, 2, 148-164.
65. Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimizu, M., Mori, A. et al. (1992). D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology, 106, 14-18.
66. Tuor, U. I., Kurpita, G., & Simone, C. (1994). Correlation of local changes in cerebral blood flow, capillary density, and cytochrome oxidase during development. Journal of Comparative Neurology, 342, 439-448.
67. Tutus, A., Simsek, A., Sofuoglu, S., Nardali, M., Kugu, N., Karaaslan, F. et al. (1998). Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders: Comparison of unipolar versus bipolar subtypes. Psychiatry Research, 83, 169-177.
68. Wong, D. F., Wagner Jr, H. N., Pearlson, G., Dannals, R. F., Links, J. M., Ravert, H. T. et al. (1985). Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: A preliminary report. Psychopharmacology Bulletin, 21, 595-598.
69. Yatham, L. N., Liddle, P. F., Lam, R. W., Adam, M. J., Solomons, K., Chinnapalli, M. et al. (2005). A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disorders, 7(Suppl.5), 53-57.
70. Yatham, L. N., Liddle, P. F., Lam, R. W., Shiah, I. S., Lane, C., Stoessl, A. J. et al. (2002a). PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and moodstabilizer- naive patients with nonpsychotic mania. American Journal of Psychiatry, 159, 1718-1723.
71. Yatham, L. N., Liddle, P. F., Shiah, I. S., Lam, R. W., Ngan, E., Scarrow, G. et al. (2002b). PET study of [(18)F]6-fluoro- L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: Effects of treatment with divalproex sodium. The American Journal of Psychiatry, 159, 768-774.
72. Yurgelun-Todd, D. A., Gruber, S. A., Kanayama, G., Killgore, W. D., Baird, A. A., & Young, A. D. (2000). fMRI during affect discrimination in bipolar affective disorder. Bipolar Disorders, 2, 237-248.
73. Zubieta, J. K., Huguelet, P., Ohl, L. E., Koeppe, R. A., Kilbourn, M. R., Carr, J. M. et al. (2000). High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates. American Journal of Psychiatry, 157, 1619-1628.
74. Zubieta, J. K., Taylor, S. F., Huguelet, P., Koeppe, R. A., Kilbourn, M. R., & Frey, K. A. (2001). Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry, 49, 110-116.